[30th June 2018] The IBTA’s monthly e-News has now been released and been emailed to all subscribers. Some of the highlights from this month include research showing that that advanced MRI—aided by artificial intelligence — may improve brain tumour diagnosis…
The IBTA is excited to announce its participation in a new program at the National Cancer Institute, Center for Cancer Research, Neuro-Oncology Branch called NCI-CONNECT (Comprehensive Oncology Network Evaluating Rare CNS Tumours)…
[14 July 2018] Copies of the 2018/19 world edition of our “Brain Tumour” magazine have been landing in the letterboxes of subscribers in over 110 countries across the globe, free of charge.
[17th March 2018] In healthcare, inefficiency is often caused by neglecting to focus on what matters most to patients. A new international patient survey is gathering insights on inefficiencies in cancer care…
[13th March 2018] New treatment options and effective precision medicine therapies are urgently required for glioblastomas (GBMs), a highly malignant and aggressive type of brain tumour…
[28th February 2018] The IBTA’s monthly e-News has now been released and has been emailed to all subscribers. Some of the highlights from the February issue include research showing that the sickle cell disease drug hydroxyurea may boost chemotherapy…
Like us on Facebook and follow us on Twitter.
The IBTA is a not-for-profit, limited liability company incorporated in England and Wales, Company Number: 6031485. © copyright 2007 - 2014 The International Brain Tumour Alliance [IBTA]. All Rights Reserved. Design by Feelingpeaky
Sitemap | Company information | Disclaimer | Privacy Policy | Cookies Website Photo Credits
